Although attention has recently been focused on the role of psychosocial factors in patients with cardiovascular disease (CVD), the factors that have the greatest influence on prognosis have not yet been elucidated. The aim of this study was to evaluate the effects of depression, anxiety, and anger on the prognosis of patients with CVD. Four hundred fourteen consecutive patients hospitalized with CVD were prospectively enrolled. Depression was evaluated using the Patient Health Questionnaire, anxiety using the Generalized Anxiety Disorder Questionnaire, and anger using the Spielberger Trait Anger Scale. Cox proportional-hazards regression was used to examine the individual effects of depression, anxiety, and anger on a combined primary end point of cardiac death or cardiac hospitalization and on a combined secondary end point of all-cause death or hospitalization during follow-up (median 14.2 months). Multivariate analysis showed that depression was a significant risk factor for cardiovascular hospitalization or death after adjusting for cardiac risk factors and other psychosocial factors (hazard ratio 2.62, p = 0.02), whereas anxiety was not significantly associated with cardiovascular hospitalization or death after adjustment (hazard ratio 2.35, p = 0.10). Anger was associated with a low rate of cardiovascular hospitalization or death (hazard ratio 0.34, p <0.01). In conclusion, depression in hospitalized patients with CVD is a stronger independent risk factor for adverse cardiac events than either anxiety or anger. Anger may help prevent adverse outcomes. Routine screening for depression should therefore be performed in patients with CVD, and the potential effects of anger in clinical practice should be reconsidered.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.Circulation. 1999; 99: 2192-2217
- Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.Eur Heart J. 2006; 27: 2763-2774
- Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.JAMA. 2008; 300: 2379-2388
- Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.Am J Cardiol. 2001; 88: 337-341
- Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.Arch Gen Psychiatry. 2008; 65: 62-71
- Anxiety worsens prognosis in patients with coronary artery disease.J Am Coll Cardiol. 2007; 49: 2021-2027
- Effects of anger on left ventricular ejection fraction in coronary artery disease.Am J Cardiol. 1992; 70: 281-285
- Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease.Am J Cardiol. 2010; 105: 1555-1560
- Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.Circulation. 2008; 118: 1768-1775
- Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study.JAMA. 1999; 282: 1737-1744
- A brief measure for assessing generalized anxiety disorder: the GAD-7.Arch Intern Med. 2006; 166: 1092-1097
- The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus.Psychol Rep. 2007; 101: 952-960
- Validation and utility of a Japanese version of the GAD-7.Panminerva Medica. 2009; 51: 79
- An attempt for the standardization of anger expression scale for Japanese.Jpn J Res Emotions. 1997; 4: 14-21
- Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction.Circulation. 1998; 97: 167-173
- The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction.Circ Cardiovasc Qual Outcomes. 2009; 2: 328-337
- Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction.Am Heart J. 2003; 146: 48-54
- A prospective study of anger and coronary heart disease. The Normative Aging Study.Circulation. 1996; 94: 2090-2095
- Hostility, age, and mortality in a sample of cardiac patients.Am J Cardiol. 2005; 96: 64-66
- Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions.Psychol Bull. 2005; 131: 260-300
- On the value of doing nothing: anger and cardiovascular disease in clinical practice.Cardiol Rev. 2007; 15: 123-132
- The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence.J Am Coll Cardiol. 2009; 53: 936-946
- Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study.Circulation. 2004; 109: 1267-1271
- Anger expression and risk of stroke and coronary heart disease among male health professionals.Psychosom Med. 2003; 65: 100-110
- Anger expression and risk of coronary heart disease: evidence from the Nova Scotia Health Survey.Am Heart J. 2010; 159: 199-206
Published online: February 22, 2013
Accepted: January 21, 2013
Received in revised form: January 21, 2013
Received: November 5, 2012
This study was supported by Science Research Grant H21-KOKORO-IPPAN-007 (Research on Psychiatric and Neurological Disease and Metal Health) from Japan's Ministry of Health, Labour and Welfare, Tokyo, Japan.
See page 1436 for disclosure information.
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.